Detection of minimal residual disease in mantle cell lymphoma-establishment of novel eight-color flow cytometry approach-Reference-Cited by-同舟云学术

Detection of minimal residual disease in mantle cell lymphoma-establishment of novel eight-color flow cytometry approach

Published:2015-01-14 Issue:2 Volume:88 Page:92-100
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Chovancová Jana¹²,Bernard Tomáš¹,Stehlíková Olga¹,Šálek David¹,Janíková Andrea¹,Mayer Jiří¹²,Doubek Michael¹²

Affiliation:

1. Department of Internal Medicine-Hematology and Oncology; University Hospital, Brno and Faculty of Medicine, Masaryk University; Brno Czech Republic

2. Central European Institute of Technology, Masaryk University; Brno Czech Republic

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference31 articles.

1. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression;Doubek;Exp Hematol,2009

2. Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL;Giebel;Bone Marrow Transpl,2010

3. Minimal residual disease detection in mantle cell lymphoma: Methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations;Boettcher;Haematologica,2008

4. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia;Dworzak;Blood,2002

5. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia;Rawstron;Leukemia,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry;Clinics in Laboratory Medicine;2023-09

2. Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma;Current Treatment Options in Oncology;2023-05-30

3. Flow cytometry to detect bone marrow involvement by follicular lymphoma;Cytometry Part B: Clinical Cytometry;2022-10-31

4. Data Analysis;Flow Cytometry Today;2022

5. Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens;BMC Cancer;2021-12